Health News Releases

  • Today January 8
April 29, 2025 17:10
SINOVAC Board Issues Letter to Shareholders to Set the Record Straight on the Hostile Actions and False Claims by Vivo Capital
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that its board of directors (the “Board”) issued a public le
Sparta, WI Facility
April 29, 2025 15:30
Actus Nutrition Acquires Protein Facility from Foremost Farms USA
Actus Nutrition (“Actus”), a leading vertically-integrated nutritional ingredients manufacturer and portfolio company of Butterfly Equity (“Butterfly”), today finalized an agreement to purchase a 99,0
April 29, 2025 09:50
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine
Ferrer (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ferrer.com&esheet=54244013&newsitemid=20250427034068&lan=en-US&anchor=Ferrer&index=1&md5=d54ab3f5c9071597c756ac15dea5202e),
VIO 3n Fire
April 27, 2025 11:30
Erbe introduces VIO® 3n & VIO® seal: Tailored electrosurgical generators for high-performance workflows
With the introduction of the VIO® 3n, Erbe Elektromedizin GmbH expands its established VIO® 3 family with a new generation of electrosurgical generators, specifically tailored to different medical spe
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea.
April 25, 2025 10:00
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PCI Pharma Services (“PCI”) - a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies - is acquiring an entire equity stake in Ajinomoto A
April 24, 2025 16:10
Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis
H.U. Group Holdings, Inc. and its wholly-owned subsidiary Fujirebio Holdings, Inc. today announced that the Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 m
April 24, 2025 14:15
Galderma Delivers Record First Quarter Net Sales of 1.129 Billion USD, Including Strong Performance From Two Launches With Blockbuster Potential, and Confirms Full-Year Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2025. · Net sales: Achieved 1,129 million USD in net sales, u
Charlene Chen, PhD, Deputy General Manager & Head of the Center of Toxicology and Preclinical Scienc
April 24, 2025 10:30
QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis
QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion of its pharmacology disease models p
April 23, 2025 15:00
Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay
Invivoscribe is proud to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM), LLC has received approval from the New York State Department of Health
Aster Guardians Global Nursing Award 2025 - Grand Jury (Photo: AETOSWire)
April 23, 2025 14:35
Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai
Aster DM Healthcare, one of the leading integrated healthcare providers in GCC & India, has announced the distinguished Grand Jury panel for the Aster Guardians Global Nursing Award 2025 to be held in
April 22, 2025 16:38
A new weapon in the global fight against malaria
Malaria is one of the world’s most deadly diseases, and it is becoming more pervasive - despite decades of effort and some successes on the path to eradicating it. According to the World Health Organi
April 22, 2025 10:35
Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug d
April 22, 2025 10:20
Ferring Announces Initial Data from Phase 3 Trial in Japanese Patients Demonstrating 75% Complete Response Rate at 3 Months with (nadofaragene firadenovec) in BCG-unresponsive NMIBC Patients1
Ferring Pharmaceuticals presented the first results from an ongoing Phase 3 trial in Japan assessing the efficacy and safety of nadofaragene firadenovec in patients with high-risk Bacillus Calmette-Gu
Left: Keitaro Iwaki, President & Representative Director, SPERA PHARMA; Right: Jun Kawakami, Preside
April 20, 2025 11:45
Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development
Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc. (headquarters: Osaka; President & Re
Jasmine Saba (left) has been appointed Sr. Vice President of Strategic Relationships. Josh Blacker (
April 18, 2025 09:55
Avania Strengthens Leadership Team With Pivotal Executive Appointments
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54239395&newsitemid=20250417247152&lan=en-US&anchor=Avania&index=1&md5=8135dbc072fb2e6f4bf0a0
Abu Dhabi Launches Life Sciences Cluster to Advance Healthcare Innovation Worldwide, tapping a $25.3
April 18, 2025 09:45
Abu Dhabi Launches Life Sciences Cluster to Advance Healthcare Innovation Worldwide, tapping a $25.3 trillion market
Abu Dhabi has launched the groundbreaking life sciences cluster, reinforcing its position as a global hub for biotechnology, MedTech, and digital health. Developed by the Abu Dhabi Department of Econo
April 17, 2025 16:39
Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®
Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their late
April 17, 2025 11:20
Kenvue Announces 5-Year Collaboration with Microsoft to Transform Digital Operations
Kenvue Inc. (NYSE: KVUE), maker of consumer health products like Tylenol®, Neutrogena® and Listerine®, today announced a five-year collaboration with Microsoft which aims to establish a strong foundat
April 15, 2025 14:35
Galderma Launches Sculptra® in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets
Galderma today announced the launch of Sculptra, the first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation, in China.[1]-[7],[11]-[14] This follows Sculptra’
Henlius Logo
April 13, 2025 10:25
European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an inve
April 13, 2025 10:15
Novotech Welcomes New Investment From GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth
Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a sig
April 10, 2025 15:00
Natus Sensory Strengthens Executive Team with Key Leadership Appointments
Natus Sensory (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fnatus.com%2F&esheet=54235965&newsitemid=20250409771212&lan=en-US&anchor=Natus+Sensory&index=1&md5=c24865accf8cec644da2a
April 10, 2025 14:20
New Coalition Calls for Urgent Action to Address Rising Stroke Crisis
Launching today, the world’s first multisector advocacy movement dedicated to stroke - the Global Stroke Action Coalition - has issued an urgent call to action to address growing inequities in stroke.
Merz Aesthetics® Announces Salma Hayek Pinault as First-Ever Global Brand Ambassador for Ultherapy PRIME®, the Next Generation Platform for Nonsurgical Skin Lifting Treatments
April 10, 2025 13:55
Merz Aesthetics® Announces Salma Hayek Pinault as First-Ever Global Brand Ambassador for Ultherapy PRIME®, the Next Generation Platform for Nonsurgical Skin Lifting Treatments
Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is proud to announce world-renowned actress, director and producer, Salma Hayek Pinault, as the first-ever global brand amb
April 10, 2025 11:40
BeiGene Provides Update on the Ociperlimab (BGB-A1217) Clinical Development Program
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the discontinuation of its clinical developmen
25 per page50 per page75 per page100 per page